Stevanato stock is trading -30.45% below its average target price of $29.08 after marking a 4.3% during today's morning session. Analysts are giving the Mid-Cap Medical Instruments & Supplies company an average rating of buy and target prices ranging from $22.21 to $37.99 per share.
The stock has an average amount of shares sold short at 5.7%, and a short ratio of 7.94. Since 2.13% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 112.8% of Stevanato's shares being owned by this investor type.
Institutions Invested in Stevanato
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-03-31 | Conestoga Capital Advisors, LLC | 2% | 6,778,893 | $137,103,113 |
| 2024-03-31 | Neuberger Berman Group, LLC | 1% | 4,396,287 | $88,914,906 |
| 2024-03-31 | Copeland Capital Management, LLC | 1% | 2,402,115 | $48,582,776 |
| 2024-03-31 | Lazard Asset Management LLC | 1% | 2,267,013 | $45,850,338 |
| 2024-03-31 | Wellington Management Group, LLP | 1% | 2,210,883 | $44,715,109 |
| 2024-03-31 | Sands Capital Management, LLC | 1% | 1,860,141 | $37,621,352 |
| 2024-03-31 | Jackson Square Partners, Llc | 1% | 1,824,240 | $36,895,254 |
| 2024-03-31 | ClearBridge Investments, LLC | 1% | 1,729,397 | $34,977,054 |
| 2024-03-31 | Times Square Capital Management, LLC | 1% | 1,626,063 | $32,887,124 |
| 2024-03-31 | William Blair Investment Management, LLC | 0% | 1,432,868 | $28,979,755 |
Besides an analyst consensus of strong upside potential, other market factors point to there being positive market sentiment on Stevanato.
